Compare Bio Protocol (BIO) vs IDEX (IDEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs IDEX — how do they compare? Bio Protocol trades at Rp439.3 (market cap Rp997,34M, Rp163,74M 24h volume), while IDEX trades at Rp33.85 (market cap Rp74,11M, Rp36,08M 24h volume). The key difference: Bio Protocol is far larger — about 13.5× IDEX's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while IDEX's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and IDEX for 20 Days on average.
| BIO | IDEX | |
|---|---|---|
Market Cap | Rp997,34M | Rp74,11M |
Volume (24h) | Rp163,74M | Rp36,08M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 1B IDEX |
Typical Hold Time | 18 Days | 20 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
IDEX token currently holds a market capitalization of Rp74,11M with 1M tokens in circulation, indicating a relatively small-cap cryptocurrency. The token shows moderate holding patterns with an average hold time of 20 days. Recent market activity suggests limited trading volume and liquidity, with the current price unavailable from verified crypto data sources. The token appears to be in a consolidation phase with minimal price volatility observed in recent trading sessions.
Overall outlook remains cautious due to limited market data and trading activity. Key opportunities include potential growth if ecosystem development accelerates, while major risks include low liquidity, limited exchange support, and vulnerability to market volatility. Investors should monitor for increased network adoption and exchange listings that could improve token accessibility and trading depth.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About IDEX
IDEX describes itself as the first hybrid liquidity DEX, merging an order book model with an automated market maker (AMM). It combines the speed and functionality of traditional order books with the security and liquidity of AMMs. By integrating an off-chain trading engine with on-chain trade settlement, IDEX offers a unique approach to decentralized exchanges.
Read more on IDEX →
